Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Mar. 31, 2018
USD ($)
| |
| Beginning balance | $ 579,026 |
| Acquisitions (Note 3) | 27,799 |
| Currency translation | 3,842 |
| Ending balance | 610,667 |
| Biotechnology [Member] | |
| Beginning balance | 254,930 |
| Acquisitions (Note 3) | 27,686 |
| Currency translation | 3,416 |
| Ending balance | 286,032 |
| Protein Platforms [Member] | |
| Beginning balance | 220,826 |
| Acquisitions (Note 3) | |
| Currency translation | 454 |
| Ending balance | 221,280 |
| Diagnostics [Member] | |
| Beginning balance | 103,270 |
| Acquisitions (Note 3) | 113 |
| Currency translation | (28) |
| Ending balance | $ 103,355 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|